Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Degenerative Disc Disease ll: Pathophysiology01:23

Degenerative Disc Disease ll: Pathophysiology

The symptoms of degenerative disc disease arise from a combination of mechanical compression, vascular compromise, and biochemical inflammation, which together disrupt nerve function and produce pain.Mechanical CompressionDisc degeneration reduces height and elasticity, predisposing to herniation of the nucleus pulposus, a major cause of radicular pain. Herniations may be protrusion (bulging with intact annulus), extrusion (nucleus extends beyond disc but remains connected), or sequestration...
Degenerative Disc Disease I: Introduction01:27

Degenerative Disc Disease I: Introduction

Degenerative disc disease is a chronic condition in which intervertebral discs gradually lose structure and function. It is not infectious or autoimmune; rather, it results from age-related biochemical and mechanical changes, influenced by genetic, metabolic, and environmental factors.Structure and Function of DiscsThe spine contains 23 intervertebral discs that absorb load, distribute forces, maintain spacing, and allow flexibility. Each disc consists of a nucleus pulposus, a gel-like core...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Structural Joints: Cartilaginous Joints01:17

Structural Joints: Cartilaginous Joints

As the name indicates, at a cartilaginous joint, the adjacent bones are united by cartilage, a tough but flexible type of connective tissue. Unlike synovial joints, these types of joints lack a joint cavity and involve bones joined together by either hyaline cartilage or fibrocartilage.
There are two types of cartilaginous joints:
Synchondrosis
A synchondrosis ("joined by cartilage") is a cartilaginous joint where bones are connected by hyaline cartilage. Synchondrosis may be temporary or...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Targeting fibroblast-like synoviocytes with CDK4/6 inhibitors as a novel, non-immunosuppressive treatment strategy for rheumatoid arthritis.

Clinical and experimental rheumatology·2025
Same author

Impact of bimekizumab and certolizumab pegol on efficacy, safety and osteoblastic activity in radiographic axial spondyloarthritis: results from a phase IIa, multicentre, randomised, double-blind, exploratory study with PET-CT imaging.

Therapeutic advances in musculoskeletal disease·2024
Same author

Differential regulation of IL-17A and IL-17F via STAT5 contributes to psoriatic disease.

The Journal of allergy and clinical immunology·2023
Same author

Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa: A Phase 2, Double-blind, Placebo-Controlled Randomized Clinical Trial.

JAMA dermatology·2021
Same author

Transcriptional regulator BOB.1: Molecular mechanisms and emerging role in chronic inflammation and autoimmunity.

Autoimmunity reviews·2021
Same author

IL-23 Inhibition in Ankylosing Spondylitis: Where Did It Go Wrong?

Frontiers in immunology·2021

関連する実験動画

Updated: May 31, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

脊椎関節炎 (Sondyloarthritis) について

Maxime Dougados1, Dominique Baeten

  • 1Paris-Descartes University, Medicine Faculty, UPRES EA 4058, AP-HP, Cochin Hospital, Department of Rheumatology B, Paris, France. m.doug@cch.aphp.fr

Lancet (London, England)
|June 21, 2011
PubMed
まとめ
この要約は機械生成です。

脊椎関節炎は,いくつかの関連疾患を網羅しており,最近の進歩により,炎症の分類と理解が向上しています. 将来の研究は,構造的損傷を停止し,長期的な寛解を達成するための早期診断と治療を目的としています.

さらに関連する動画

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

関連する実験動画

Last Updated: May 31, 2026

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
06:23

Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis

Published on: May 23, 2021

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis
04:47

Du-Moxibustion in a Mouse Model of Ankylosing Spondylitis

Published on: October 27, 2023

科学分野:

  • レウマトロジーの病理学
  • 免疫学 免疫学とは
  • 遺伝学 遺伝学とは

背景:

  • 脊椎関節炎は,多性関節炎,炎症性腸疾患に関連する関節炎,反応性関節炎,若年性イディオパシー関節炎,性脊椎炎を含む関連疾患のスペクトルです.
  • 過去10年の著しい進歩により,脊椎関節炎の根底にある遺伝的および病理生理学的メカニズムの認識,分類,理解が向上しました.
  • 臨床およびイメージングの成果の進歩は,治療介入の評価を容易にする.

研究 の 目的:

  • 脊椎関節炎の分類と基礎となるメカニズムを含む,現在の理解をレビューする.
  • 最近の治療の進歩,特に腫瘍死滅因子阻害剤の影響を評価する.
  • 脊椎関節炎の管理における主要な課題と将来の方向性を特定する.

主な方法:

  • 脊椎関節炎の研究における最近の進歩に関する文献レビュー.
  • 現在の治療方法とその有効性の分析.
  • 満たされていないニーズと将来の研究優先事項の特定.

主要な成果:

  • 腫瘍死滅因子阻害剤は,大きな治療的ブレークスルーを表しています.
  • 理学療法,非ステロイド性抗炎症薬,その他の生物学的治療の正確な役割については,さらなる解明が必要である.
  • 病気のメカニズム,炎症,組織損傷の理解において,進歩が示されています.

結論:

  • 早期診断技術は,効果的な管理に不可欠です.
  • 治療戦略は,構造的損傷を調節することに焦点を当てるべきである.
  • 究極の目標は,脊椎関節炎の患者の長期的,薬剤なしの寛解を誘導することです.